Przedsiębiorstwo Wdrażania Innowacyjnych Technologii Newtechsp. z o.o.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2013-08-01
Share capital
5,000.00 PLN
Registered address
Katowicka 144/-, 41-500 Chorzów, Poland
Email
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 23 days early.
- 202506/07/2026
- 202410/07/2025
- 202310/07/2024
- 202205/07/2023
- 202107/07/2022
- 202009/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 8.44kMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD 7.40kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 301.69MedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 239.78kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Stanisław Bogusław Słapek – President of the Management Board
Roman Jan Chabior – Vice President of the Management Board
Manner of representation
Each member of the management board is authorised to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Roman Jan Chabiorage 70 | 50 | $675.31 | 50% |
Stanisław Bogusław Słapekage 55 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | PREZYDENT MIASTA CHORZÓW |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrum Innowacji i Wdrożeń Bio-Inwestsp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| ArthecS.A. | $10,911.16 | arthec.eu | ||
| Vitagenumsp. z o.o. | $9,376.94 | vitagenum.pl | ||
| 4cell TherapiesS.A. | $9,123.06 | 4celltherapies.com | ||
| Meritrosp. z o.o. | $7,890.74 | meritro.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | ||
| MAP Your Dna Spólka z Ograniczoną Odpowiedzialnościąsp. z o.o. | $7,283.38 | mapyourdna.eu | ||
| Medical Algorithmssp. z o.o. | $682.08 | medicalalgorithms.eu | ||
| Codagenesp. z o.o. | – | codagene.com |
Change history
| Date | Event | |
|---|---|---|
| 2021-02-10 | PKD change (Removed: 212 codes) | |
| 2013-09-19 | Name change (Przedsiębiorstwo Wdrażania Innowacyjnych Technologii "new Tech" → Przedsiębiorstwo Wdrażania Innowacyjnych Technologii "newtech") | |
| 2013-08-01 | Entered in the register |
FAQ
The main business activity of Przedsiębiorstwo Wdrażania Innowacyjnych Technologii Newtech focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on August 1, 2013.
The headquarters is located at: Katowicka 144, 41-500 Chorzów.
The management board consists of: Stanisław Bogusław Słapek (President of the Management Board) and Roman Jan Chabior (Vice President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $594 in 2024, which is a decrease of 50.8% compared to 2023.
Yes, in 2024 the company was profitable, achieving a net profit of $271, meaning the company increased its profit by 130.8%.
The largest operating cost category falls under other operating costs. This category amounted to $296 in 2024, representing 100% of all operating expenses.
Last updated: 2026-07-09
